Remote Monitoring and Telehealth for High Blood Pressure
(vCCC 2 Trial)
Trial Summary
What is the purpose of this trial?
This is a randomized, controlled, pragmatic trial designed as a "type I hybrid effectiveness-implementation trial" that tests a hypertension program integrating a virtual Collaborative Care Clinic (vCCC), home blood pressure monitoring, and telehealth for lowering blood pressure (BP) in two health systems.
Research Team
Jeffrey Burns
Principal Investigator
University of Kansas Medical Center
Eligibility Criteria
This trial is for people aged 65 and older with high blood pressure who can hear well, speak English, use a smartphone or similar device, and have Medicare. They must not be in hospice care, on dialysis for kidney failure, receiving chemotherapy or other trials' interventions, diagnosed with dementia or any severe illness that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Virtual Collaborative Care Clinic (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
Dr. Steve Stites
University of Kansas Medical Center
Chief Executive Officer
MD from University of Kansas School of Medicine
Dr. Matthias Salathe
University of Kansas Medical Center
Chief Medical Officer
MD from University of Kansas School of Medicine
University of Missouri-Columbia
Collaborator
Mun Y. Choi
University of Missouri-Columbia
Chief Executive Officer since 2017
PhD in Mechanical and Aerospace Engineering from Princeton University
Richard Barohn
University of Missouri-Columbia
Chief Medical Officer since 2020
MD from the University of Missouri-Columbia School of Medicine
University of Utah
Collaborator
Jeffrey Wilkins
University of Utah
Chief Medical Officer since 2022
MD from Meharry Medical College
Stephen Tullman
University of Utah
Chief Executive Officer since 2022
BS in Accounting from Rutgers University